352 related articles for article (PubMed ID: 38012409)
1. The immunometabolic ecosystem in cancer.
Bantug GR; Hess C
Nat Immunol; 2023 Dec; 24(12):2008-2020. PubMed ID: 38012409
[TBL] [Abstract][Full Text] [Related]
2. Fundamentals of T Cell Metabolism and Strategies to Enhance Cancer Immunotherapy.
Rangel Rivera GO; Knochelmann HM; Dwyer CJ; Smith AS; Wyatt MM; Rivera-Reyes AM; Thaxton JE; Paulos CM
Front Immunol; 2021; 12():645242. PubMed ID: 33815400
[TBL] [Abstract][Full Text] [Related]
3. Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy.
Yin Z; Bai L; Li W; Zeng T; Tian H; Cui J
J Exp Clin Cancer Res; 2019 Sep; 38(1):403. PubMed ID: 31519198
[TBL] [Abstract][Full Text] [Related]
4. ATP-exhausted nanocomplexes for intratumoral metabolic intervention and photoimmunotherapy.
Yu M; Zeng W; Ouyang Y; Liang S; Yi Y; Hao H; Yu J; Liu Y; Nie Y; Wang T; Deng Y; Wu M
Biomaterials; 2022 May; 284():121503. PubMed ID: 35367841
[TBL] [Abstract][Full Text] [Related]
5. Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.
Bahrambeigi S; Shafiei-Irannejad V
Biochem Pharmacol; 2020 Apr; 174():113787. PubMed ID: 31884044
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive tumor microenvironment modulation by chemotherapies and targeted therapies to enhance immunotherapy effectiveness.
Barnestein R; Galland L; Kalfeist L; Ghiringhelli F; Ladoire S; Limagne E
Oncoimmunology; 2022; 11(1):2120676. PubMed ID: 36117524
[TBL] [Abstract][Full Text] [Related]
7. Dysfunctional T cell metabolism in the tumor microenvironment.
Beckermann KE; Dudzinski SO; Rathmell JC
Cytokine Growth Factor Rev; 2017 Jun; 35():7-14. PubMed ID: 28456467
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms and Implications of Metabolic Heterogeneity in Cancer.
Kim J; DeBerardinis RJ
Cell Metab; 2019 Sep; 30(3):434-446. PubMed ID: 31484055
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-driven metabolic heterogeneity and immune evasive behaviour of gastrointestinal cancers: Elements of a recipe for disaster.
Mishra AK; Singh SK; Dayanandan S; Banerjee S; Chakraborty S; Gopal AB; Samal S; Poirah I; Chakraborty D; Bhattacharyya A
Cytokine; 2022 Aug; 156():155917. PubMed ID: 35660715
[TBL] [Abstract][Full Text] [Related]
10. Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment.
Sasidharan Nair V; Saleh R; Toor SM; Cyprian FS; Elkord E
Cancer Immunol Immunother; 2021 Aug; 70(8):2103-2121. PubMed ID: 33532902
[TBL] [Abstract][Full Text] [Related]
11. Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges.
Pacella I; Piconese S
Front Immunol; 2019; 10():1889. PubMed ID: 31507585
[TBL] [Abstract][Full Text] [Related]
12. Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.
Yan L; Tan Y; Chen G; Fan J; Zhang J
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638609
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy.
Kishton RJ; Sukumar M; Restifo NP
Cell Metab; 2017 Jul; 26(1):94-109. PubMed ID: 28683298
[TBL] [Abstract][Full Text] [Related]
14. Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing.
Bai R; Cui J
Front Immunol; 2022; 13():890166. PubMed ID: 35833121
[TBL] [Abstract][Full Text] [Related]
15. Remodeling metabolic fitness: Strategies for improving the efficacy of chimeric antigen receptor T cell therapy.
Shen L; Xiao Y; Tian J; Lu Z
Cancer Lett; 2022 Mar; 529():139-152. PubMed ID: 35007698
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Barriers to T Cell Function in Tumors.
Sugiura A; Rathmell JC
J Immunol; 2018 Jan; 200(2):400-407. PubMed ID: 29311381
[TBL] [Abstract][Full Text] [Related]
17. CD147‑mediated reprogrammed glycolytic metabolism potentially induces immune escape in the tumor microenvironment (Review).
Li X; Xu W
Oncol Rep; 2019 May; 41(5):2945-2956. PubMed ID: 30864716
[TBL] [Abstract][Full Text] [Related]
18. [Metabolic Competition in Tumor Microenvironment].
Eikawa S; Udono H
Gan To Kagaku Ryoho; 2017 Nov; 44(11):972-976. PubMed ID: 29138369
[TBL] [Abstract][Full Text] [Related]
19. Targeting Cell Metabolism as Cancer Therapy.
Ngoi NYL; Eu JQ; Hirpara J; Wang L; Lim JSJ; Lee SC; Lim YC; Pervaiz S; Goh BC; Wong ALA
Antioxid Redox Signal; 2020 Feb; 32(5):285-308. PubMed ID: 31841375
[No Abstract] [Full Text] [Related]
20. Major fundamental factors hindering immune system in defense against tumor cells: The link between insufficiency of innate immune responses, metabolism, and neurotransmitters with effector immune cells disability.
Bahrambeigi S; Sanajou D; Shafiei-Irannejad V
Immunol Lett; 2019 Aug; 212():81-87. PubMed ID: 31260743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
